MDGL
USDMadrigal Pharmaceuticals Inc. Common Stock
リアルタイム価格
価格チャート
主要指標
市場指標
始値
$488.030
高値
$494.550
安値
$477.000
出来高
0.76M
企業ファンダメンタルズ
時価総額
11.1B
業種
バイオテクノロジー
国
United States
取引統計
平均出来高
0.37M
取引所
NMS
通貨
USD
52週レンジ
関連ニュース
B of A Securities Upgrades Madrigal Pharmaceuticals to Neutral, Raises Price Target to $445
B of A Securities analyst Alexandria Hammond upgrades Madrigal Pharmaceuticals from Underperform to Neutral and raises the price target from $266 to $445.
Madrigal to Present New Data from the Company's MASH Program at AASLD's The Liver Meeting 2025
Two oral presentations to highlight biomarker, imaging and quality-of-life data from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial of RezdiffraPoster of distinction examines the
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
CONSHOHOCKEN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated
Truist Securities Initiates Coverage On Madrigal Pharmaceuticals with Buy Rating, Announces Price Target of $580
Truist Securities analyst Srikripa Devarakonda initiates coverage on Madrigal Pharmaceuticals with a Buy rating and announces Price Target of $580.
関連株式
MSBIP
Midland States Bancorp Inc. Depositary Shares Each Representing a 1/40th Interest in a Share of 7.750% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock Series A
ERAS
Erasca Inc.
PRAA
PRA Group Inc.
USCB
USCB Financial Holdings Inc.
BIIB
Biogen Inc.
最新情報を入手
価格アラートを設定し、AI分析の更新とリアルタイム市場ニュースを受け取る。